Galectin Therapeutics, Inc. GALT was a big mover last session, as the company saw its shares rise nearly 9% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company as the stock is now down about 13% in the past one-month time frame.
In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged. However, yesterday's price action is encouraging, so make sure to keep a close watch on this firm in the near future.
Galectin Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the healthcare industry include Alexion Pharmaceuticals, Inc. ALXN, with a Zacks Rank #1 (Strong Buy) along with Actelion Ltd. (ALIOF) and Cambrex Corporation.CBM holding a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ACTELION LTD (ALIOF): Get Free Report
ALEXION PHARMA ALXN: Free Stock Analysis Report
CAMBREX CORP CBM: Free Stock Analysis Report
GALECTIN THERAP GALT: Get Free Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
